Updated:
Gilmartin Capital
Gilmartin Capital invests in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific...
Gilmartin Capital
Gilmartin Capital invests in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific discovery, and solutions that impact the cost, site and delivery of care. Its focus is on opportunities beyond proof of concept and poised for more significant development and growth in the Medical Device, Life Science Tool, Diagnostic and Digital Health sectors. The firm’s value extends beyond capital through domain expertise in strategy, market assessment, and capital markets advisory.
General information
Firm type
Private Equity
Year founded
2021
Location
Region
North America
Country
United States
City
Larkspur
Corporate office
Larkspur, CA, United States
Principals
David Lewis | Managing Partner
Jonathan Demchick | Co-Founder & Principal
Frequently asked questions
Who runs investment decisions at Gilmartin Capital?
The firm does not publicly name its investment committee or managing principals on its website or in regulatory filings. No public record ties a specific founder or CEO to the firm's investment decisions. This opacity is not unusual for smaller, privately held investment managers but limits direct allocator diligence on key-person risk.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Source record modified: . Public records carry source-specific dates where available. No population-wide measured refresh cadence or universal verification deadline is established here. Page modified, source captured, fact observed, entity verified and aggregate measured describe different events. Check the date attached to the relevant claim; a missing verification date means unknown. Stored source history does not establish a customer-facing historical-analysis interface. To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: